We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today.
- Authors
Oprea-Lager, Daniela-Elena; MacLennan, Steven; Dierckx, Rudi; Fanti, Stefano
- Abstract
The article discusses the fifth edition of the European Association of Nuclear Medicine (EANM) Focus meeting on "molecular imaging and theranostics in prostate cancer." The meeting aimed to review developments in molecular hybrid imaging and systemic radioligand therapy for prostate cancer and reach a consensus on the current state-of-the-art in diagnosis and treatment. The meeting included experts from various medical specialties and resulted in consensus on several statements, including the use of PSMA PET for staging and restaging prostate cancer and the definition of oligometastatic disease. However, there were still uncertainties on certain topics, highlighting the need for ongoing collaboration and education in the field.
- Subjects
OLDER men; PROSTATE cancer; CASTRATION-resistant prostate cancer; COMPANION diagnostics
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2024, Vol 51, Issue 5, p1462
- ISSN
1619-7070
- Publication type
Article
- DOI
10.1007/s00259-023-06552-2